BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 31318794)

  • 21. Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer.
    Bratu LD; Schenker M; Stovicek PO; Schenker RA; Mehedințeanu AM; Berisha TC; Donoiu A; Mogoantă SȘ
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674302
    [No Abstract]   [Full Text] [Related]  

  • 22. Total neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia.
    Tuta M; Boc N; Brecelj E; Omejc M; Anderluh F; Ermenc AS; Peressutti AJ; Oblak I; Krebs B; Velenik V
    Radiol Oncol; 2019 Oct; 53(4):465-472. PubMed ID: 31652124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
    Ryan JE; Warrier SK; Lynch AC; Heriot AG
    Colorectal Dis; 2015 Oct; 17(10):849-61. PubMed ID: 26260213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of total neoadjuvant therapy for locally advanced rectal cancer.
    Feng W; Yu B; Zhang Z; Li J; Wang Y
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):546-559. PubMed ID: 34818447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodal assessment after total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer accurately predicts complete responders.
    Özoran E; Özata İH; Uymaz DS; Omarov N; Bozkurt E; Tüfekçi T; Karahan SN; Gürbüz B; Selçukbiricik F; Bölükbaşı Y; Taşkın OÇ; Gürses B; Rencüzoğulları A; Buğra D; Balık E
    Int J Colorectal Dis; 2023 Sep; 38(1):229. PubMed ID: 37707664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-course radiation with consolidation chemotherapy does not increase operative morbidity compared to long-course chemoradiation: A retrospective study of the US rectal cancer consortium.
    Bauer PS; Gamboa AC; Otegbeye EE; Chapman WC; Rivard S; Regenbogen S; Mohammed M; Holder-Murray J; Wiseman JT; Ejaz A; Edwards-Hollingsworth K; Hawkins AT; Hunt SR; Balch G; Silviera ML
    J Surg Oncol; 2024 Feb; 129(2):254-263. PubMed ID: 37792637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes.
    Kong JC; Soucisse M; Michael M; Tie J; Ngan SY; Leong T; McCormick J; Warrier SK; Heriot AG
    Ann Surg Oncol; 2021 Nov; 28(12):7476-7486. PubMed ID: 33891203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of total neoadjuvant therapy in locally advanced rectal cancer: a meta-analysis.
    Xiong K; Bao T; Cao Y; Hu W; Deng J; Chen J; Xiao T
    Int J Colorectal Dis; 2023 Apr; 38(1):89. PubMed ID: 37004572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucinous Rectal Adenocarcinoma Is Associated with a Poor Response to Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis.
    McCawley N; Clancy C; O'Neill BD; Deasy J; McNamara DA; Burke JP
    Dis Colon Rectum; 2016 Dec; 59(12):1200-1208. PubMed ID: 27824706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review.
    Teo MTW; McParland L; Appelt AL; Sebag-Montefiore D
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):146-158. PubMed ID: 29254769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
    Ryan JE; Warrier SK; Lynch AC; Ramsay RG; Phillips WA; Heriot AG
    Colorectal Dis; 2016 Mar; 18(3):234-46. PubMed ID: 26531759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
    Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
    Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.
    An X; Lin X; Wang FH; Goodman K; Cai PQ; Kong LH; Fang YJ; Gao YH; Lin JZ; Wan DS; Pan ZZ; Ding PR
    Eur J Cancer; 2013 Mar; 49(4):843-51. PubMed ID: 23063351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Donnelly M; Ryan OK; Ryan ÉJ; Creavin B; O'Reilly M; McDermott R; Kennelly R; Hanly A; Martin ST; Winter DC
    Br J Surg; 2023 Sep; 110(10):1316-1330. PubMed ID: 37330950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.
    Zhao L; Liu R; Zhang Z; Li T; Li F; Liu H; Li G
    Colorectal Dis; 2016 Aug; 18(8):763-72. PubMed ID: 27169752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in adoption of total neoadjuvant therapy for locally advanced rectal cancer.
    Unuvar M; Blansfield J; Wang S; Hoffman RL
    Am J Surg; 2024 Jan; 227():229-236. PubMed ID: 37923661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Total Neoadjuvant Therapy vs. Standard Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis of Randomized Trials.
    Riesco-Martinez MC; Fernandez-Martos C; Gravalos-Castro C; Espinosa-Olarte P; La Salvia A; Robles-Diaz L; Modrego-Sanchez A; Garcia-Carbonero R
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Wu Q; Zhou J; Huang J; Deng X; Li C; Meng W; He Y; Wang Z
    Br J Surg; 2023 Jun; 110(7):784-796. PubMed ID: 37191308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant Radiotherapy Dose Escalation in Locally Advanced Rectal Cancer: a Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes.
    Hearn N; Atwell D; Cahill K; Elks J; Vignarajah D; Lagopoulos J; Min M
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e1-e14. PubMed ID: 32669228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.